Dysregulated activation of c-Src in gestational trophoblastic disease contributes to its aggressive progression

Our findings indicate an important role of c-Src in the pathogenesis of GTD, and we propose that c-Src inhibitors are potential adjuvant chemotherapeutic drugs for the treatment of GTD.